![Brian Loeb](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian Loeb
Direktor/Vorstandsmitglied bei
MycoTechnology, Inc.
Profil
Brian Loeb is currently a Director at MycoTechnology, Inc., a Director at Arzeda Corp., a Board Member at Prenexus Health LLC, a Board Member at Plasma Nutrition LLC, and Co-Head at Conti Ventures.
He previously worked as an Advisor at Magnises, Inc. from 2013 to 2014.
Mr. Loeb received a graduate degree from Yale University and a graduate degree from the London School of Economics & Political Science.
Aktive Positionen von Brian Loeb
| Unternehmen | Position | Beginn |
|---|---|---|
Conti Ventures
 Conti Ventures Investment ManagersFinance Conti Ventures invests in companies located in the United States. The firm focuses on ag biotech, digital infrastructure, alternative protein, novel ingredients, animal health/nutrition, and downstream enterprise technology for restaurants and retailers sectors and industries. It provides financing for early and later stage capital requirements. | Corporate Officer/Principal | 01.01.2016 |
Arzeda Corp.
 Arzeda Corp. BiotechnologyHealth Technology Operates as a synthetic biology company | Direktor/Vorstandsmitglied | - |
MycoTechnology, Inc.
 MycoTechnology, Inc. Food: Specialty/CandyConsumer Non-Durables Operates as a food technology and ingredient company that focused on transforming food with natural fermentation & fungal biology | Direktor/Vorstandsmitglied | - |
Prenexus Health LLC
 Prenexus Health LLC Miscellaneous Commercial ServicesCommercial Services Engages in scientific research, development and production of natural prebiotic ingredients | Direktor/Vorstandsmitglied | - |
Plasma Nutrition LLC
 Plasma Nutrition LLC Packaged SoftwareTechnology Services Builds ioProtein and other ingredient optimized supplements products | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Brian Loeb
| Unternehmen | Position | Ende |
|---|---|---|
Magnises, Inc.
 Magnises, Inc. Finance/Rental/LeasingFinance Offers payment cards to registered members | Berater | 01.06.2014 |
Ausbildung von Brian Loeb
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
8
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
MycoTechnology, Inc.
MycoTechnology, Inc. Food: Specialty/CandyConsumer Non-Durables Operates as a food technology and ingredient company that focused on transforming food with natural fermentation & fungal biology | Consumer Non-Durables |
Magnises, Inc.
Magnises, Inc. Finance/Rental/LeasingFinance Offers payment cards to registered members | Finance |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London School of Economics & Political Science
 London School of Economics & Political Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arzeda Corp.
Arzeda Corp. BiotechnologyHealth Technology Operates as a synthetic biology company | Health Technology |
Prenexus Health LLC
Prenexus Health LLC Miscellaneous Commercial ServicesCommercial Services Engages in scientific research, development and production of natural prebiotic ingredients | Commercial Services |
Plasma Nutrition LLC
Plasma Nutrition LLC Packaged SoftwareTechnology Services Builds ioProtein and other ingredient optimized supplements products | Technology Services |
Conti Ventures
Conti Ventures Investment ManagersFinance Conti Ventures invests in companies located in the United States. The firm focuses on ag biotech, digital infrastructure, alternative protein, novel ingredients, animal health/nutrition, and downstream enterprise technology for restaurants and retailers sectors and industries. It provides financing for early and later stage capital requirements. | Finance |
